Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frohlich

Showing results (1111-1120 of 1,208) with videos related to

Pageof 121
Sort By:
Cancer Research|November 5, 2002
Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profilingWeigang Wang, Jeffrey B Wyckoff, Victoria Centonze Frohlich, et al.
Molecular Autism|November 12, 2019
Correction to: Mechanisms underlying the EEG biomarker in Dup15q syndromeJoel Frohlich, Lawrence T Reiter, Vidya Saravanapandian, et al.
Microbiology (Reading, England)|July 9, 2011
Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cellsJin Wang, Kyla M Frohlich, Lyndsey Buckner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neuPrema P Peethambaram, Michelle E Melisko, Kristine J Rinn, et al.
Molecular Autism|July 18, 2019
Mechanisms underlying the EEG biomarker in Dup15q syndromeJoel Frohlich, Lawrence T Reiter, Vidya Saravanapandian, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2009
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingKelly P Cosgrove, Erica Krantzler, Erin B Frohlich, et al.
Lancet (London, England)|December 17, 2022
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trialJohn H Krystal, John M Kane, Christoph U Correll, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerNadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
The Milbank Quarterly|January 1, 1996
Population health and health care use: an information system for policy makersN P Roos, C Black, N Frohlich, et al.
Pageof 121

Showing results (1111-1120 of 1,208) with videos related to

Sort By:
Pageof 121
Cancer Research|November 5, 2002
Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profilingWeigang Wang, Jeffrey B Wyckoff, Victoria Centonze Frohlich, et al.
Molecular Autism|November 12, 2019
Correction to: Mechanisms underlying the EEG biomarker in Dup15q syndromeJoel Frohlich, Lawrence T Reiter, Vidya Saravanapandian, et al.
Microbiology (Reading, England)|July 9, 2011
Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cellsJin Wang, Kyla M Frohlich, Lyndsey Buckner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neuPrema P Peethambaram, Michelle E Melisko, Kristine J Rinn, et al.
Molecular Autism|July 18, 2019
Mechanisms underlying the EEG biomarker in Dup15q syndromeJoel Frohlich, Lawrence T Reiter, Vidya Saravanapandian, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2009
Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smokingKelly P Cosgrove, Erica Krantzler, Erin B Frohlich, et al.
Lancet (London, England)|December 17, 2022
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trialJohn H Krystal, John M Kane, Christoph U Correll, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerNadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
The Milbank Quarterly|January 1, 1996
Population health and health care use: an information system for policy makersN P Roos, C Black, N Frohlich, et al.
Pageof 121